{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T07:51:26Z","timestamp":1783842686990,"version":"3.55.0"},"publisher-location":"Boston, MA","reference-count":67,"publisher":"Springer US","isbn-type":[{"value":"9781461362678","type":"print"},{"value":"9781461529200","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1993]]},"DOI":"10.1007\/978-1-4615-2920-0_14","type":"book-chapter","created":{"date-parts":[[2011,12,3]],"date-time":"2011-12-03T22:50:07Z","timestamp":1322952607000},"page":"83-93","source":"Crossref","is-referenced-by-count":37,"title":["Drug Delivery to Brain and the Role of Carrier-Mediated Transport"],"prefix":"10.1007","author":[{"given":"Quentin R.","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"14_CR1","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1111\/j.1471-4159.1988.tb10596.x","volume":"50","author":"M Aoyagi","year":"1988","unstructured":"Aoyagi, M., Agranoff, B.W., Washburn, L.C., and Smith, Q.R., Blood-brain barrier transport of 1-aminocyclohexanecarboxylic acid, a nonmetabolizable amino acid for in vivo studies of brain transport, J. Neurochem. 50: 1220, 1988.","journal-title":"J. Neurochem."},{"key":"14_CR2","doi-asserted-by":"publisher","first-page":"912","DOI":"10.3171\/jns.1990.72.6.0912","volume":"72","author":"K Black","year":"1990","unstructured":"Black, K., King, W.A., and Ikezaki, K., Selective opening of the blood-tumor barrier by intracarotid infusion of leukotriene C4, J. Neurosurg. 72: 912, 1990.","journal-title":"J. Neurosurg."},{"key":"14_CR3","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3171\/jns.1986.64.2.0284","volume":"64","author":"JB Blacklock","year":"1986","unstructured":"Blacklock, J.B., Wright, D.C., Dedrick, R.L., Blasberg, R.G., Lutz, R.J., Doppman, J.L., and Oldfield, E.H., Drug streaming during intra-arterial chemotherapy, J. Neurosurg. 64: 284, 1986.","journal-title":"J. Neurosurg."},{"key":"14_CR4","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0022-3565(25)30311-3","volume":"195","author":"RG Blasberg","year":"1975","unstructured":"Blasberg, R.G., Patlak, C.S., and Fenstermacher, J.D., Intrathecal chemotherapy: brain tissue profiles after ventriculocisternal perfusion, J. Pharmacol. Exp. Ther. 195: 73, 1975.","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"14_CR5","first-page":"633","volume":"61","author":"RG Blasberg","year":"1977","unstructured":"Blasberg, R.G., Patlak, C.S., and Shapiro, W.R., Distribution of methotrexate in the cerebrospinal fluid and brain after intraventricular administration, Cancer Treat. Rep. 61: 633, 1977.","journal-title":"Cancer Treat. Rep."},{"key":"14_CR6","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1126\/science.6857264","volume":"221","author":"N Bodor","year":"1983","unstructured":"Bodor, N., and Simpkins, J.W., Redox delivery system for brain-specific, sustained release of dopamine, Science 221: 65, 1983.","journal-title":"Science"},{"key":"14_CR7","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/S0065-7743(08)61178-1","volume":"22","author":"N Bodor","year":"1987","unstructured":"Bodor, N., and Kaminski, J.J., Prodrugs and site-specific chemical delivery systems, Ann. Rep. Med. Chem. 22: 303, 1987.","journal-title":"Ann. Rep. Med. Chem."},{"key":"14_CR8","first-page":"51","volume":"6","author":"JE Chastain","year":"1990","unstructured":"Chastain, J.E., and Borchardt, R.T., Acivicin transport across brain microvessel endothelial cell monolayers: a model of the blood-brain barrier, Neurosci. Res. Commun. 6: 51, 1990.","journal-title":"Neurosci. Res. Commun."},{"key":"14_CR9","volume-title":"Implications of the Blood-Brain Barrier and Its Manipulation","author":"S Chou","year":"1989","unstructured":"Chou, S., and Dix, R.D., Viral infections and the blood-brain barrier, in: \u201cImplications of the Blood-Brain Barrier and Its Manipulation, Vol. 2,\u201d E.A. Neuwelt, ed., Plenum, New York, 1989."},{"key":"14_CR10","first-page":"138","volume":"52","author":"EM Cornford","year":"1992","unstructured":"Cornford, E.M., Young, D., Paxton, J.W., Finlay, G.J., Wilson, W.R., and Pardridge, W.M., Melphalan penetration of the blood-brain barrier via the neutral amino acid transporter in tumor-bearing brain, Cancer Res. 52: 138, 1992.","journal-title":"Cancer Res."},{"key":"14_CR11","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/0006-8993(91)90212-E","volume":"554","author":"MI Damaj","year":"1991","unstructured":"Damaj, M.I., Urien, S., Trouvin, J.H., Chanut, EM Lambrey, B., and Jacquot, C., In vivo evidence for carrier-mediated brain uptake of a new 2-amino-2-oxazoline (COR3224) via the purine transport system in rat, Brain Res. 554: 333, 1991.","journal-title":"Brain Res."},{"key":"14_CR12","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/0005-2736(79)90344-4","volume":"557","author":"R Deves","year":"1979","unstructured":"Deves, R., and Krupka, R.M., The binding and translocation steps in transport as related to substrate structure: a study of the choline carrier of erythrocytes, Biochim. Biophys. Acta 557: 469, 1979.","journal-title":"Biochim. Biophys. Acta"},{"key":"14_CR13","first-page":"1251","volume":"50","author":"I Fekete","year":"1990","unstructured":"Fekete, I., Griffith, O.W., Schlageter, K.E., Bigner, D.D., Friedman, H.S., and Groothuis, D.R., Rate of buthionine sulfoximine entry into brain and xenotransplanted human gliomas, Cancer Res. 50: 1251, 1990.","journal-title":"Cancer Res."},{"key":"14_CR14","volume-title":"Implications of the Blood-Brain Barrier and Its Manipulation","author":"JD Fenstermacher","year":"1989","unstructured":"Fenstermacher, J.D., Pharmacology of the blood-brain barrier, in: \u201cImplications of the Blood-Brain Barrier and Its Manipulation, Vol. 1,\u201d E.A. Neuwelt, ed., Plenum, New York, 1989."},{"key":"14_CR15","first-page":"519","volume":"61","author":"JD Fenstermacher","year":"1977","unstructured":"Fenstermacher, J.D., and Cowles, A.L., Theoretical limitations of intracarotid infusions in brain tumor chemotherapy, Cancer Treat. Rep. 61: 519, 1977.","journal-title":"Cancer Treat. Rep."},{"key":"14_CR16","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1111\/j.1471-4159.1991.tb03460.x","volume":"56","author":"S Fukui","year":"1991","unstructured":"Fukui, S., Schwarcz, R., Rapoport, S.I., Takada, Y., and Smith, Q.R., Blood-brain barrier transport of kynurenines: implications for brain synthesis and metabolism, J. Neurochem. 56: 2007, 1991.","journal-title":"J. Neurochem."},{"key":"14_CR17","volume-title":"Implications of the Blood-Brain Barrier and Its Manipulation","author":"NH Greig","year":"1989","unstructured":"Greig, N.H., Drug delivery to the brain by blood-brain barrier circumvention and drug modification, in: \u201cImplications of the Blood-Brain Barrier and Its Manipulation, Vol. 1,\u201d E.A. Neuwelt, ed., Plenum, New York, 1989."},{"key":"14_CR18","first-page":"1571","volume":"47","author":"NH Greig","year":"1987","unstructured":"Greig, N.H., Momma, S., Sweeney, D.J., Smith, Q.R., and Rapoport, S.I., Facilitated transport of melphalan at the rat blood-brain barrier by the large neutral amino acid carrier system, Cancer Res. 47: 1571, 1987.","journal-title":"Cancer Res."},{"key":"14_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF00262729","volume":"21","author":"NH Greig","year":"1988","unstructured":"Greig, N.H., Sweeney, D.J., and Rapoport, S.I., Comparative brain and plasma pharmacokinetics and anticancer activities of chlorambucil and melphalan in the rat, Cancer Chemother. Pharmacol. 21: 1, 1988.","journal-title":"Cancer Chemother. Pharmacol."},{"key":"14_CR20","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/BF02897227","volume":"26","author":"NH Greig","year":"1990","unstructured":"Greig, N.H., Soncrant, T.T., Shetty, H.U., Momma, S., Smith, Q.R., and Rapoport, S.I., Brain uptake and anticancer activities of vincristine and vinblastine are restricted by their low cerebrovascular permeability and binding to plasma constituents in rat, Cancer Chemother. Pharmacol. 26: 263, 1990a.","journal-title":"Cancer Chemother. Pharmacol."},{"key":"14_CR21","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1007\/BF00686230","volume":"25","author":"NH Greig","year":"1990","unstructured":"Greig, N.H., Daly, E., Sweeney, D.J., and Rapoport, S.I., Pharmacokinetics of chlorambucil-tertiary butyl ester, a lipophilic chlorambucil derivative that achieves and maintains high concentrations in brain, Cancer Chemother. Pharmacol. 25: 320, 1990b.","journal-title":"Cancer Chemother. Pharmacol."},{"key":"14_CR22","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/BF00686229","volume":"25","author":"NH Greig","year":"1990","unstructured":"Greig, N.H., Genka, S., Daly, E.M., Sweeney, D.J., and Rapoport, S.I., Physiolchemical and pharmacokinetic parameters of seven lipophilic chlorambucil esters designed for brain penetration, Cancer Chemother. Pharmacol. 25: 311, 1990c.","journal-title":"Cancer Chemother. Pharmacol."},{"key":"14_CR23","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1021\/jm00386a017","volume":"30","author":"DR Haines","year":"1987","unstructured":"Haines, D.R., Fuller, R.W., Ahmad, S., Vistaca, D.T., and Marquez, V.E., Selective cytotoxicity of a system L specific amino acid nitrogen mustard, J. Med. Chem. 30: 542, 1987.","journal-title":"J. Med. Chem."},{"key":"14_CR24","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1021\/jm00379a019","volume":"28","author":"JN Jacob","year":"1985","unstructured":"Jacob, J.N., Shashoua, V.E., Campbell, A., and Baldessarini, R.J., Gamma-aminobutyric acid esters. 2. Synthesis, brain uptake, and pharmacological properties of lipid esters of gamma-aminobutyric acid, J. Med. Chem. 28: 106, 1985.","journal-title":"J. Med. Chem."},{"key":"14_CR25","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/0006-8993(89)90040-1","volume":"483","author":"H Koenig","year":"1989","unstructured":"Koenig, H., Goldstone A.D., and Chung, Y.L., Polyamines mediate the reversible opening of the blood-brain barrier by the intracarotid infusion of hyperosmolal mannitol, Brain Res. 483: 110, 1989.","journal-title":"Brain Res."},{"key":"14_CR26","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/ana.410200212","volume":"20","author":"KL Leenders","year":"1986","unstructured":"Leenders, K.L., Poewe, W.H., and Palmer, A.J., Inhibition of L-[18F]fluorodopa uptake into human brain by amino acids demonstrated by positron emission tomography, Ann. Neurol. 20: 258, 1986.","journal-title":"Ann. Neurol."},{"key":"14_CR27","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1021\/jm00180a022","volume":"23","author":"VA Levin","year":"1980","unstructured":"Levin, V.A., Relationship of octanol\/water partition coefficient and molecular weight to rat brain capillary permeability. J. Med. Chem. 23: 682, 1980.","journal-title":"J. Med. Chem."},{"key":"14_CR28","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/BF01059646","volume":"8","author":"VA Levin","year":"1980","unstructured":"Levin, V.A., Patlak, C.S., and Landahl, H.L., Heuristic modeling of drug delivery to malignant brain tumors. J. Pharmacokin. Biopharm. 8: 257, 1980.","journal-title":"J. Pharmacokin. Biopharm."},{"key":"14_CR29","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1097\/00002826-198902000-00006","volume":"12","author":"MR Luquin","year":"1989","unstructured":"Luquin, M.R., Vaamonde, J., and Obeso, J.A., Levodopa and 3-O-methyldopa plasma levels in parkinsonian patients with stable and fluctuating motor response, Clin. Neuropharmacol. 12: 46, 1989.","journal-title":"Clin. Neuropharmacol."},{"key":"14_CR30","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1126\/science.887937","volume":"197","author":"DC Markovitz","year":"1977","unstructured":"Markovitz, D.C., and Fernstrom, J.D., Diet and uptake of Aldomet into brain: competition with natural large neutral amino acids, Science 197: 1014, 1977.","journal-title":"Science"},{"key":"14_CR31","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0022-3565(25)20476-1","volume":"259","author":"H Matsushita","year":"1991","unstructured":"Matsushita, H., Suzuki, H., Sugiyama, Y., Sawada, Y., Iga, T., Kawaguchi, Y., and Hanano, M., Facilitated transport of cefodizime into the rat central nervous system, J. Pharmacol. Exp. Ther. 259: 620, 1991.","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"14_CR32","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1159\/000238553","volume":"34","author":"A Meulemans","year":"1988","unstructured":"Meulemans, A., Vicart, P., Mohler, J., and Vulpillat, M., Determination of antibiotic lipophilicity with a micromethod: application to brain permeability in man and rats, Chemotherapy 34: 90, 1988.","journal-title":"Chemotherapy"},{"key":"14_CR33","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1111\/j.1471-4159.1987.tb05660.x","volume":"48","author":"S Momma","year":"1987","unstructured":"Momma, S., Aoyagi, M., Rapoport, S.I., and Smith, Q.R., Phenylalanine transport across the blood-brain barrier as studied with the in situ brain perfusion technique, J. Neurochem. 48: 1291, 1987.","journal-title":"J. Neurochem."},{"key":"14_CR34","volume-title":"Implications of the Blood-Brain Barrier and Its Manipulation","author":"EA Neuwelt","year":"1989","unstructured":"Neuwelt, E.A., and Dahlborg, S.A., Blood-brain barrier disruption in the treatment of brain tumors: clinical implications, in: \u201cImplications of the Blood-Brain Barrier and Its Manipulation, Vol. 2,\u201d E.A. Neuwelt, ed., Plenum, New York, 1989."},{"key":"14_CR35","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1200\/JCO.1991.9.9.1580","volume":"9","author":"EA Neuwelt","year":"1991","unstructured":"Neuwelt, E.A., Goldman, D.L., Dahlborg, S.A., Crossen, J., Ramsey, F., Roman-Goldstein, S., Braziel, R., and Dana, B., Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: prolonged survival with preservation of cognitive function, J. Clin. Oncol. 9: 1580, 1991.","journal-title":"J. Clin. Oncol."},{"key":"14_CR36","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1002\/ana.410210610","volume":"21","author":"JG Nutt","year":"1987","unstructured":"Nutt, J.G., Woodward, W.R., Gancher, ST., and Merrick, D., Methyldopa and the response to levodopa in Parkinson\u2019s disease, Ann. Neurol. 21: 584, 1987.","journal-title":"Ann. Neurol."},{"key":"14_CR37","volume-title":"Narcotics and the Hypothalamus","author":"WH Oldendorf","year":"1974","unstructured":"Oldendorf, W.H., Drug penetration of the blood-brain barrier, in:\u201dNarcotics and the Hypothalamus,\u201d E. Zimmermann and R. George, eds., Raven Press, New York, 1974."},{"key":"14_CR38","first-page":"H299","volume":"235","author":"K Ohno","year":"1979","unstructured":"Ohno, K., Pettigrew, K.D., and Rapoport, S.I., Lower limits of cerebrovascular permeability to nonelectrolytes in the conscious rat, Am.J. Physiol. 235: H299, 1979.","journal-title":"Am.J. Physiol."},{"key":"14_CR39","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1007\/BF01926490","volume":"29","author":"WM Pardridge","year":"1973","unstructured":"Pardridge, W.M., and Connor, J.D., Saturable transport of amphetamine across the blood-brain barrier, Experientia 29: 302, 1973.","journal-title":"Experientia"},{"key":"14_CR40","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1111\/j.1471-4159.1980.tb06621.x","volume":"34","author":"WM Pardridge","year":"1980","unstructured":"Pardridge, W.M., and Mietus, L.J., Palmitate and cholesterol transport through the blood-brain barrier, J. Neurochem. 34: 463, 1980.","journal-title":"J. Neurochem."},{"key":"14_CR41","first-page":"R582","volume":"247","author":"WM Pardridge","year":"1984","unstructured":"Pardridge, W.M., Sakiyama, R., and Fierer, G., Blood-brain barrier transport and brain sequestration of propranolol and lidocaine, Am.J. Physiol. 247: R582, 1984.","journal-title":"Am.J. Physiol."},{"key":"14_CR42","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1210\/endo-126-2-977","volume":"126","author":"WM Pardridge","year":"1990","unstructured":"Pardridge, W.M., Triguero, D., and Buciak, J.L., \u00df-Endorphin chimeric peptides: transport through the blood-brain barrier in vivo and cleavage of disulfide linkage by brain, Endocrinology 126: 971, 1990.","journal-title":"Endocrinology"},{"key":"14_CR43","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0022-3565(25)20567-5","volume":"259","author":"WM Pardridge","year":"1991","unstructured":"Pardridge, W.M., Buciak, J.L., and Friden, P.M., Selective transport of an anti-transferrin receptor antibody through the blood-brain barrier, J. Pharmacol. Exp. Ther. 259: 66, 1991.","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"14_CR44","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/0006-8993(79)90546-8","volume":"172","author":"SI Rapoport","year":"1979","unstructured":"Rapoport, S.I., Ohno, K., and Pettigrew, K.D., Drug entry into the brain, Brain Res. 172: 354, 1979.","journal-title":"Brain Res."},{"key":"14_CR45","first-page":"R421","volume":"238","author":"SI Rapoport","year":"1980","unstructured":"Rapoport, S.I., Fredericks, W.R., Ohno, K., and Pettigrew, K.D., Quantitative aspects of reversible osmotic opening of the blood-brain barrier, Am.J. Physiol. 238;R421, 1980.","journal-title":"Am.J. Physiol"},{"key":"14_CR46","first-page":"R459","volume":"253","author":"PJ Robinson","year":"1987","unstructured":"Robinson, P.J., and Rapoport, S.I., Size selectivity of blood-brain barrier permeability at various times after osmotic opening, Am.J. Physiol. 253: R459, 1987.","journal-title":"Am.J. Physiol."},{"key":"14_CR47","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1111\/j.1749-6632.1991.tb15631.x","volume":"633","author":"LL Rubin","year":"1991","unstructured":"Rubin, L.L., Barbu, K., Bard, F., Cannon, C., Hall, D.E., Homer, H., Janatpour, M., Liaw, C., Manning, K., Morales, J., Porter, S., Tanner, L., Tomaselli, K., and Yednock, T., New York Acad. Sci. 633: 420, 1991.","journal-title":"New York Acad. Sci."},{"key":"14_CR48","volume-title":"Brain Energy Metabolism","author":"BK Siesj\u00f6","year":"1978","unstructured":"Siesj\u00f6, B.K., \u201cBrain Energy Metabolism,\u201d John Wiley & Sons, Chichester, 1978."},{"key":"14_CR49","first-page":"696","volume":"47","author":"PS Schein","year":"1987","unstructured":"Schein, P.S., Green, D., Dean, S.W., and McPherson, E., 6-[Bis(2-chloroethyl)amino]-6-deoxygalactopyranose hydrochloride (C6-galactose mustard), a new alkylating agent with reduced bone marrow toxicity, Cancer Res. 47: 696, 1987.","journal-title":"Cancer Res."},{"key":"14_CR50","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/jcbfm.1985.39","volume":"5","author":"QR Smith","year":"1985","unstructured":"Smith, Q.R., Takasato, Y., Sweeney, D.J., and Rapoport, S.I., Regional cerebrovascular transport of leucine as measured by the in situ brain perfusion technique, J. Cereb. Blood Flow Metabol. 5: 300, 1985.","journal-title":"J. Cereb. Blood Flow Metabol."},{"key":"14_CR51","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1111\/j.1471-4159.1987.tb01039.x","volume":"49","author":"QR Smith","year":"1987","unstructured":"Smith, Q.R., Momma, S., Aoyagi, M., and Rapoport, S.I., Kinetics of neutral amino acid transport across the blood-brain barrier, J. Neurochem. 49: 1651, 1987.","journal-title":"J. Neurochem."},{"key":"14_CR52","first-page":"1025","volume":"15","author":"QR Smith","year":"1989","unstructured":"Smith, Q.R., Aoyagi, M., and Rapoport, S.I., Structural specificity of the brain capillary neutral amino acid transporter, Soc. Neurosci. Abstr. 15: 1025, 1989.","journal-title":"Soc. Neurosci. Abstr."},{"key":"14_CR53","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1093\/infdis\/156.1.209","volume":"156","author":"R Spector","year":"1987","unstructured":"Spector, R., Ceftriaxone transport through the blood-brain barrier, J. Infect. Dis. 156: 209, 1987.","journal-title":"J. Infect. Dis."},{"key":"14_CR54","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1172\/JCI107767","volume":"54","author":"R Spector","year":"1974","unstructured":"Spector, R., and Lorenzo, A.V., Inhibition of penicillin transport from the cerebrospinal fluid after intracisternal inoculation of bacteria, J. Clin. Invest. 54: 316, 1974.","journal-title":"J. Clin. Invest."},{"key":"14_CR55","volume-title":"Transport and Diffusion across Cell Membranes","author":"WD Stein","year":"1986","unstructured":"Stein, W.D., \u201cTransport and Diffusion across Cell Membranes,\u201d Academic Press, Orlando, 1986."},{"key":"14_CR56","volume-title":"Implications of the Blood-Brain Barrier and Its Manipulation","author":"LJ Strausbaugh","year":"1989","unstructured":"Strausbaugh, L.J., Meningitis, antimicrobial agents, and the blood-brain barrier, in: \u201cImplications of the Blood-Brain Barrier and Its Manipulation, Vol. 2,\u201d E.A. Neuwelt, ed., Plenum, New York, 1989."},{"key":"14_CR57","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1248\/bpb1978.12.182","volume":"12","author":"H Suzuki","year":"1989","unstructured":"Suzuki, H., Sawada, Y., Sugiyama, Y., Iga, T., and Hanano, M., Facilitated transport of benzylpenicillin through the blood-brain barrier in rats, J. Pharmacobio-Dyn. 12: 182, 1989.","journal-title":"J. Pharmacobio-Dyn."},{"key":"14_CR58","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/BF00687316","volume":"29","author":"Y Takada","year":"1991","unstructured":"Takada, Y., Greig, N.H., Vistica, D.T., Rapoport, S.I., and Smith, Q.R., Affinity of antineoplastic amino acid drugs for the large neutral amino acid transporter of the blood-brain barrier, Cancer Chemother. Pharmacol. 29: 89, 1991.","journal-title":"Cancer Chemother. Pharmacol."},{"key":"14_CR59","first-page":"2191","volume":"52","author":"Y Takada","year":"1992","unstructured":"Takada, Y., Vistica, D.T., Greig, N.H., Purdon, D., Rapoport, S.I., and Smith, Q.R., Rapid high-affinity transport of a chemotherapeutic amino acid across the blood-brain barrier, Cancer Res. 52: 2191, 1992.","journal-title":"Cancer Res."},{"key":"14_CR60","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1093\/infdis\/158.3.630","volume":"158","author":"T Terasaki","year":"1988","unstructured":"Terasaki, T., and Pardridge, W.M., Restricted transport of 3\u2032-azido-3\u2032-deoxythymidine and dideoxynucleosides through the blood-brain barrier, J. Infect. Dis. 158: 630, 1988.","journal-title":"J. Infect. Dis."},{"key":"14_CR61","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1023\/A:1015959628008","volume":"5","author":"JBMM Bree van","year":"1988","unstructured":"van Bree, J.B.M.M., Audus, K.L., and Borchardt, R.T., Carrier-mediated transport of baclofen across monolayers of bovine brain endothelial cells in primary culture, Pharm. Res. 5: 369, 1988.","journal-title":"Pharm. Res."},{"key":"14_CR62","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1023\/A:1015812725011","volume":"8","author":"JBMM Bree van","year":"1991","unstructured":"van Bree, J.B.M.M., Heijligers-Feijen, CD., de Boer, A.G., Danhof, M., and Breimer, D.D., Stereoselective transport of baclofen across the blood-brain barrier in the rats as determined by the unit impulse response methodology, Pharm. Res. 8: 259, 1991.","journal-title":"Pharm. Res."},{"key":"14_CR63","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1111\/j.1471-4159.1975.tb04415.x","volume":"25","author":"LA Wade","year":"1975","unstructured":"Wade, L.A., and Katzman, R., Synthetic amino acids and the nature of L-DOPA transport at the blood-brain barrier, J. Neurochem. 25: 837, 1975a.","journal-title":"J. Neurochem."},{"key":"14_CR64","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/0024-3205(75)90248-9","volume":"17","author":"LA Wade","year":"1975","unstructured":"Wade, L.A., and Katzman, R., 3-O-Methyldopa uptake and inhibition of L-dopa at the blood-brain barrier, Life Sci. 17: 131, 1975b.","journal-title":"Life Sci."},{"key":"14_CR65","first-page":"5475","volume":"50","author":"MG Williams","year":"1990","unstructured":"Williams, M.G., Earhart, R.H., Bailey, H., and McGovern, J.P., Prevention of central nervous system toxicity of the antitumor antibiotic acivicin by concomitant infusion of an amino acid mixture, Cancer Res. 50: 5475, 1990.","journal-title":"Cancer Res."},{"key":"14_CR66","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/0006-8993(84)91191-0","volume":"322","author":"H Levitan","year":"1984","unstructured":"Levitan, H., Ziylan, Z., Smith, Q.R., Takasato, Y., and Rapoport, S.I., Brain uptake of a food dye, erythrosin B, prevented by plasma protein binding, Brain Res. 322: 131, 1984.","journal-title":"Brain Res."},{"key":"14_CR67","first-page":"R634","volume":"247","author":"YZ Ziylan","year":"1984","unstructured":"Ziylan, Y.Z., Robinson, P.J., and Rapoport, S.I., Blood-brain barrier permeability to sucrose and dextran after osmotic opening, Am.J. Physiol. 247: R634, 1984.","journal-title":"Am.J. Physiol."}],"container-title":["Advances in Experimental Medicine and Biology","Frontiers in Cerebral Vascular Biology"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4615-2920-0_14.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T20:42:46Z","timestamp":1741984966000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4615-2920-0_14"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993]]},"ISBN":["9781461362678","9781461529200"],"references-count":67,"URL":"https:\/\/doi.org\/10.1007\/978-1-4615-2920-0_14","relation":{},"ISSN":["0065-2598"],"issn-type":[{"value":"0065-2598","type":"print"}],"subject":[],"published":{"date-parts":[[1993]]}}}